Form 4: OptimizeRx Executive Receives Stock Grant
Insider Transaction (Form 4)
Andrew J. D'Silva, Chief Business Officer of OptimizeRx Corp, received 57,600 shares of common stock on August 20, 2026.
Summary
- Grant/award: acquired 57,600 Common Stock on August 20, 2026; holds 101,092 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew J. D'Silva — Officer (Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Grant/award | Common Stock | 57,600 | — | — | 101,092 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Grant/award (57,600 shares) |
Keywords
insider transaction, Form 4, OPRX, OptimizeRx Corp, neutral, Andrew J. D'Silva
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.